申请人:BAYER INTELLECTUAL PROPERTY GmbH
公开号:US20140100243A1
公开(公告)日:2014-04-10
The present application relates to novel substituted 4-aryl-1,4-dihydro-1,6-naphthyridine-3-carboxamides, a process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.
本申请涉及新型取代的4-芳基-1,4-二氢-1,6-萘啶-3-羧酰胺,它们的制备方法,它们用于治疗和/或预防疾病的用途,以及它们用于制造治疗和/或预防疾病的药物,尤其是心血管疾病。